Table 2.
Methods to identify patients who may be receiving long-acting naltrexone therapy
| Method | Details |
|---|---|
| Communication | Contact continuity providers, family, and friends who may have knowledge of treatments for opioid abuse disorder |
| Medical records | May be listed under “procedures” or “medication” records |
| Examination | If an implant has been placed, inspect and palpate the abdomen for a firm, subcutaneous object |
| Laboratory tests | Available commercially from Quest Diagnostics (urine) and NMS Labs (serum) |